124 related articles for article (PubMed ID: 10806126)
1. Pancreatitis following hepatitis A vaccination.
Haviv YS; Sharkia M; Galun E; Safadi R
Eur J Med Res; 2000 May; 5(5):229-30. PubMed ID: 10806126
[TBL] [Abstract][Full Text] [Related]
2. Cell mediated and antibody immune response to inactivated hepatitis A vaccine.
Schmidtke P; Habermehl P; Knuf M; Meyer CU; Sänger R; Zepp F
Vaccine; 2005 Oct; 23(44):5127-32. PubMed ID: 16054733
[TBL] [Abstract][Full Text] [Related]
3. [Reactivity and immunogenicity of Havrix 360 vaccine for hepatitis A].
Borcić B; Kovac S; Mihaljević I; Dobrovsak-Sourek V; Ljubicić M
Lijec Vjesn; 1996; 118(7-8):162-4. PubMed ID: 8965633
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis A and vaccination.
Teuwen DE
Arch Inst Pasteur Tunis; 1994; 71(3-4):549-56. PubMed ID: 8801857
[No Abstract] [Full Text] [Related]
5. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
Kanra G; Yalçin SS; Ceyhan M; Yurdakök K
Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.
Dagan R; Greenberg D; Weber F
Vaccine; 2005 Oct; 23(44):5144-8. PubMed ID: 16043271
[TBL] [Abstract][Full Text] [Related]
8. [Hepatitis A vaccine].
Mussa GC; Borgione S; Mussa F; Silvestro L
Minerva Pediatr; 1995 Nov; 47(11):439-44. PubMed ID: 8684338
[No Abstract] [Full Text] [Related]
9. Supplementary statement on hepatitis A prevention.
Can Commun Dis Rep; 1996 Jan; 22(1):1-3. PubMed ID: 8825660
[TBL] [Abstract][Full Text] [Related]
10. Supplementary statement on hepatitis A prevention. Laboratory Centre for Disease Control.
CMAJ; 1996 Aug; 155(3):302-5. PubMed ID: 8705911
[No Abstract] [Full Text] [Related]
11. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community.
Barkai G; Belmaker I; Givon-Lavi N; Dagan R
Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466
[TBL] [Abstract][Full Text] [Related]
12. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India?
Anand AC; Nagpal AK; Seth AK; Dhot PS
J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.
Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061
[TBL] [Abstract][Full Text] [Related]
14. Acute hepatitis A in a traveler who had received preexposure inactivated hepatitis A virus vaccine.
Kurup A; San LM; Yew WS
Clin Infect Dis; 1999 Jun; 28(6):1324-5. PubMed ID: 10451178
[No Abstract] [Full Text] [Related]
15. Hepatitis A vaccine: which dose is best?
Lonergan G
JAMA; 1995 Apr; 273(13):999-1000. PubMed ID: 7897815
[No Abstract] [Full Text] [Related]
16. Long-term immunogenicity of an inactivated virosome hepatitis A vaccine.
Bovier PA; Bock J; Loutan L; Farinelli T; Glueck R; Herzog C
J Med Virol; 2002 Dec; 68(4):489-93. PubMed ID: 12376955
[TBL] [Abstract][Full Text] [Related]
17. Time course of hepatitis A viremia and viral load in the blood of human hepatitis A patients.
Normann A; Jung C; Vallbracht A; Flehmig B
J Med Virol; 2004 Jan; 72(1):10-6. PubMed ID: 14635005
[TBL] [Abstract][Full Text] [Related]
18. Rapid antibody response after vaccination with a virosomal hepatitis a vaccine.
Ambrosch F; Finkel B; Herzog C; Koren A; Kollaritsch H
Infection; 2004 Jun; 32(3):149-52. PubMed ID: 15188074
[TBL] [Abstract][Full Text] [Related]
19. Concomitant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial.
Dagan R; Amir J; Livni G; Greenberg D; Abu-Abed J; Guy L; Ashkenazi S; Foresner G; Tewald F; Schätzl HM; Hoffmann D; Ibanez R; Herzog C
Pediatr Infect Dis J; 2007 Sep; 26(9):787-93. PubMed ID: 17721372
[TBL] [Abstract][Full Text] [Related]
20. [Safety and immunogenicity of a new inactivated hepatitis A vaccine].
Ren A; Ma J; Feng F
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Dec; 15(4):357-9. PubMed ID: 11986726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
